1.Clinical Experience in Treating Pregnancy Uterine Cavity Effusion by Tonifying Kidney to Remove Blood Stasis
Journal of Zhejiang Chinese Medical University 2016;(1):34-35
Objective]To explore clinical experience in treating pregnancy uterine cavity effusion by tonifying kidney to remove blood stasis. [Method] With the study of TCM literature on pregnancy uterine cavity effusion, by combining with clinical practice, it expounds pathogenesis and treatment of syndrome differentiation of pregnancy uterine cavity effusion. [Result]The main pathogenesis of this disease focuses on kidney deficiency and blood stasis which can impair Chong and Ren channels,inducing insecurity of the fetal origin,so the clinical treatment principle centers on tonifying kidney to remove blood stasis,and the self-decoction that is the basic recipe may change with symptom, making the fetal origin secure. [Conclusion] Method of tonifying kidney to remove blood stasis is quite effective for pregnancy uterine cavity effusion in clinic,and it is worth further study.
2.Strengthening Management of Hospital Infection
Aiyu YU ; Kailing ZHANG ; Xiaoli FANG
Chinese Journal of Nosocomiology 2009;0(24):-
OBJECTIVE To strengthen the management of hospital infection in order to prevent and control the hospital infection.METHODS Management organizations,various systems,knowledge training and monitorings should be strengthened.RESULTS Through the strengthening of hospital infection management,the sense of control and the hospital rules and regulations were improved.CONCLUSIONS The hospital medical staff improve their sense of control and management of hospital infection and strengthen the management standardization and institutionalization,and sustainably promote the management of hospital infection.
3.Clinical application of contrast-enhanced ultrasound in inflammatory hepatocellular adenoma
Kailing CHEN ; Weibin ZHANG ; Feng MAO ; Beijian HUANG ; Peili FAN ; Qi ZHANG ; Wenping WANG
Chinese Journal of Ultrasonography 2021;30(1):48-53
Objective:To investigate the contrast-enhanced ultrasound (CEUS) features of inflammatory hepatocellular adenoma (I-HCA).Methods:The contrast-enhanced ultrasound features I-HCA of 28 cases from April 2009 to November 2019 in Zhongshan Hospital, Fudan University were retrospectively analyzed, including arterial phase enhancement pattern, the homogeneity of enhancement, subcapsular enhancement, and the internal perfusion defect. All I-HCA lesions were divided into >5 cm group( n=9) and ≤5 cm group( n=19), the CEUS features between the two groups were compared. Results:All I-HCA lesions were hyper-enhanced in the arterial phase, among which 39.3% (11/28) showed diffuse filling, 39.3%(11/28) showed centripetal filling, and 21.4%(6/28) showed centrifugal filling pattern. Twenty-five percent (7/28) of I-HCAs showed heterogeneous enhancement, 10.7% (3/28) revealed unenhanced areas within the lesions. Subcapsular vessels were observed in 67.7 (21/31) of I-HCA lesions. Heterogeneous enhancement and unenhanced areas were more frequently detected in lesions >5 cm ( P=0.020, 0.026, respectively), while there was no difference in the enhancement pattern and subcapsular vessels between the two groups ( P>0.05). Inportal venous phase, 42.9%(12/28) of I-HCAs showed hypo-enhancement, and 57.1%(16/28) of lesions showed washout in late phase. According to "hyper-enhancement in arterial phase, sustained hyper- or iso-enhancement in portal venous and late phase" by CEUS, the diagnostic accuracy of benign lesion was 42.9%(12/28). According to any of hyper-enhancement pattern in arterial phase, subcapsular vascular enhancement, and sustained hyper- or iso-enhancement in portal venous and late phase, the diagnostic accuracy of I-HCA was 71.4% (20/28). Conclusions:CEUS is valuable in the diagnosis of inflammatory hepatocellular adenoma.
4.Mechanism of action of intestinal farnesoid X receptor in nonalcoholic fatty liver disease and related targeted drugs
Journal of Clinical Hepatology 2020;36(5):1160-1163
The incidence rate of nonalcoholic fatty liver disease (NAFLD) is gradually increasing in recent years, and the treatment of NAFLD is unsatisfactory due to the failure in lifestyle adjustment and a lack of effective drugs. Farnesoid X receptor (FXR), as the main bile acid receptor, may affect NAFLD by participating in glucose and fat metabolism, and intestinal FXR (iFXR) acts on the intestinal tract alone and may thus avoid the side effects of systemic release. Therefore, it may have potential value in the treatment of NAFLD, but there are also certain controversies. This article reviews the research advances in the role of iFXR in NAFLD.
5. Impact of carbon dioxide pneumoperitoneum in operating rooms on the health of medical staffs
Weiguo CHEN ; Huan SHAN ; Jinming YE ; Peiwei ZHANG ; Kailing JIN ; Kai LIN ; Wenjie CHU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2017;35(3):193-195
Objective:
To evaluate the impact of CO2 pneumoperitoneum in operating rooms on the health of medical staffs.
Methods:
In June 2016, the thirty-three medical staffs in operating rooms were chosen as the object of the research.Seventeen people who took part in the pneumoperitoneum operation were selected as a exposure group and sixteen people who took part in the laparotomy operation were selected as a control group.Vital signs and arterial blood gases of medical staffs in the two groups were both measured in pre-operation and post-operation. Occupational Health Questionnaires were conducted to collect information on age, weight and postoperative symptoms. The level of CO2 in operating room was determined by a portable infrared CO2 analyzer.
Results:
Compared with the control group, the concentration of CO2 in the exposed group was higherat T1, T2 and T3 (
6.Protective effect of microRNA-155 antisense oligonucleotid on lipopolysaccharide-induced acute lung injury in mice
Jin TANG ; Wang XIE ; Tingting CHENG ; Kailing WANG ; Xia GU ; Qian ZHANG ; Zhongliang GUO
Chinese Critical Care Medicine 2018;30(8):743-747
ObjectiveTo investigate the protective effect of microRNA-155 (miR-155) antisense oligonucleotid (ASO) on acute lung injury (ALI) mice by establishing a lentiviral expression vector of ASO of miRNA.Methods miR-155 antisense oligonucleotides amplified by polymerase chain reaction (PCR) from genomic, using BamH Ⅰ and Nhe Ⅰ double digestion, ligated into lentiviral expression vector. Sequence and virus titer were measured. According to the random number table method, 54 male BALB/c mice of 4-6 weeks old were divided into three groups. ALI animal models were prepared by intraperitoneal injection of 10 mg/kg lipopolysaccharide (LPS). The three groups were injected with 200μL phosphate buffered saline (PBS) containing 1×108/mL pmiR-155-ASO virus (pmiR-155-ASO group) or 200μL PBS containing 1×108/mL pSMPUW-miR-GFP empty virus (pmiR-cont group) or the same amount of PBS (PBS group) at 24 hours before the molding. Ten mice in each group were used to observe the 7-day survival rate. Blood samples and lung tissues of the remaining 8 mice were harvested after the model was established, and the levels of serum inflammatory cytokines were determined by enzyme linked immunosorbent assay (ELISA); the expression of miR-155 in lung tissue was detected by real-time reverse transcription-polymerase chain reaction (RT-PCR); histopathological changes of lung and distribution of macrophages were observed under microscope.Results There was no significant difference in each index between pmiR-cont group and PBS group. The mature miR-155 expression in lung tissue in pmiR-155-ASO group was significantly lower than that in pmiR-cont group (2-ΔΔCt: 4.92±0.72 vs. 15.38±0.60,P < 0.05). Compared with pmiR-cont group, the injury degree of ALI mice after pretreatment with miR-155ASO was significantly improved, and the 7-day survival rate was significantly increased (72.1% vs. 61.9%,P < 0.05 ); gross lung observation showed that congestion in lung tissue was significantly reduced, and the ratio of wet/dry weight (W/D) of lung was significantly decreased (4.50±0.13 vs. 5.64±0.61,P < 0.05);hematoxylin-eosin (HE) staining showed that inflammatory cell infiltration in lung tissue was decreased, while immunofluorescence assay showed that macrophage infiltration in lung tissue was significant decreased; the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL- 6) in serum were significantly decreased [TNF-α (ng/L):379.8±48.9 vs. 495.9±33.3, IL-6 (ng/L): 262.3±61.8 vs. 355.4±22.6, bothP < 0.05], but the level of IL-10 did not change significantly (ng/L: 143.6±32.5 vs. 140.4±22.3,P > 0.05).Conclusion miR-155 ASO has the effect of inhibiting LPS-induced inflammatory response and improving prognosis in ALI mice.
7.Stability and pharmacokinetics of hyaluronic acid-modified asparaginase self-assembled biomimetic nanocapsules
Yuying LIU ; Yao LI ; Qiang YANG ; Ran CHEN ; Kailing LI ; Jingqing ZHANG
Journal of China Pharmaceutical University 2020;51(4):462-466
The stability and pharmacokinetic properties of hyaluronic acid-modified asparaginase (Asp) self-assembled bionic nanocapsules (ASNCs) were preliminarily investigated. ASNCs were prepared by molecular self-assembly method to investigate their morphology, particle size, zeta potential and antitrypsin stability. After intravenous injection of free Asp and ASNCs, rat plasma samples at different times were taken to determine Asp activity. Pharmacokinetic parameters were calculated by DAS pharmacokinetic software. The particle size of ASNCs was (99.17 ± 0.21) nm and the potential was -(13.13 ± 0.60) mV. In trypsin solution, ASNCs showed more excellent stability. The area under the activity-time curve (AUC0-48 h) of ASNCs was about 2 times higher than that of Asp; the mean residence time (MRT0-48 h) was about 1.7 times higher than that of Asp, and the bioavailability was 195% of Asp. The results showed that ASNCs could improve the stability and bioavailability of Asp against trypsin and prolong the circulation time of Asp in vivo.
8. Ethanol extract of costusroot protects gastric mucosal in gastric ulcer rats by regulating the protein expression of Bcl-2 and Bax
Na LEI ; Kailing ZHANG ; Hao ZHU ; Yuannan XU ; Peixin GUO ; Yuhuan XIE ; Yun CHEN
Chinese Journal of Clinical Pharmacology and Therapeutics 2021;26(12):1370-1378
AIM: To explore the effect of ethanol extract of costusroot (EEC) on gastric mucosa in gastric ulcer rats and related mechanism. METHODS: The rats were randomly divided into 5 groups: normal group, model group, sucralfate group, low-EEC group and high-EEC group, and anhydrous alcohol was administrated intragastrically to replicate gastric ulcer model in groups other than the normal. Changes in the area of gastric ulcer were observed and the inhibition rate of ulcer was calculated. The pathological changes of gastric tissue were measured by HE staining, and the protein expression levels of Bax and Bcl-2 were tested by immunohistochemistry and Western blot. RESULTS: EEC inhibited the formation of ulcer area in model rats and alleviated the histopathological damage to the stomach caused by ethanol. While enhancing the expression of Bcl-2 protein (P<0.01), it effectively inhibited the overexpression of Bax (P<0.01). CONCLUSION: EEC has a strong function of anti-gastric ulcers, and its mechanism of action might be related to the regulation of the protein expression level of Bax and Bcl-2 to inhibit the apoptosis of gastri mucosal cells.